Dose‐dependent impact of proton pump inhibitors on the clinical course of spontaneous bacterial peritonitis-Reference-Cited by-同舟云学术

Dose‐dependent impact of proton pump inhibitors on the clinical course of spontaneous bacterial peritonitis

Published:2018-05-07 Issue:9 Volume:38 Page:1602-1613
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Tergast Tammo L.¹,Wranke Anika¹,Laser Hans²,Gerbel Svetlana²,Manns Michael. P.¹³⁴,Cornberg Markus¹³⁴,Maasoumy Benjamin¹³^ORCID

Affiliation:

1. Department of Gastroenterology, Hepatology and EndocrinologyHannover Medical School Hannover Germany

2. Centre for Information Management (ZIMt)Hannover Medical School Hannover Germany

3. German Centre for Infection Research (Deutsches Zentrum für Infektionsforschung DZIF), Partner‐site Hannover‐Braunschweig Hannover Germany

4. Centre for Individualised Infection Medicine (CIIM)c/o CRC Hannover Hannover Germany

Funder

Else Kröner-Fresenius-Stiftung

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/liv.13862

Reference31 articles.

1. Bacterial infections in cirrhosis: Epidemiological changes with invasive procedures and norfloxacin prophylaxis

2. Increased risk of cognitive impairment in cirrhotic patients with bacterial infections

3. Acute‐on‐chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis;Moreau R;Gastroenterology,2013

4. Albumin Infusion Improves Outcomes of Patients With Spontaneous Bacterial Peritonitis: A Meta-analysis of Randomized Trials

5. Infections in Patients With Cirrhosis Increase Mortality Four-Fold and Should Be Used in Determining Prognosis

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proton Pump Inhibitors in Patients with Cirrhosis: Pharmacokinetics, Benefits and Drawbacks;Current Gastroenterology Reports;2024-08-21

2. Letter: Risks of proton pump inhibitor treatment in cirrhotic patients—Authors' reply;Alimentary Pharmacology & Therapeutics;2024-07-12

3. Editorial: Novel insights into the prognostic relevance of high‐dose PPI treatment in patients with cirrhosis;Alimentary Pharmacology & Therapeutics;2024-04-23

4. High‐dose proton pump inhibitor treatment is associated with a higher mortality in cirrhotic patients: A multicentre study;Alimentary Pharmacology & Therapeutics;2024-02-22

5. Proton Pump Inhibitors Increases Longitudinal Risk of Mortality, Decompensation, and Infection in Cirrhosis: A Meta-Analysis;Digestive Diseases and Sciences;2023-11-15